TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Pulmonary Emphysema Market Set to Expand by 2034 with Rising COPD Prevalence and Therapeutic Innovation | DelveInsight

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Delveinsight
Pulmonary Emphysema Market Set to Expand by 2034 with Rising COPD Prevalence and Therapeutic Innovation | DelveInsight

The pulmonary emphysema market is projected to grow steadily by 2034, driven by increasing COPD prevalence, an aging population, and advances in therapeutic treatments. Emerging therapies and innovative drugs are expected to transform the market landscape.

Insights
SNY   positive

Developing SAR-447537, an experimental recombinant fusion protein for treating alpha-1 antitrypsin deficiency, showing innovative approach to emphysema treatment